Janux Therapeutics’ $60 Million Offering of Common Stock and Pre-Funded Warrants

Pietro Martinoia
Tagged:

Cooley advised Janux, and Latham & Watkins advised the underwriter on the offering.Janux Therapeutics, Inc. (Nasdaq: JANX) has announced the pricing of an underwritten offering of 4,153,717…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now